Bottom Line
Intekplus is the narrow, deep leader at the inspection chokepoint of the semiconductor quad capex cycle. But the turnaround expectation is already in the price, and the next move up must be proven by 2027 order disclosures.
Inspection-equipment maker Intekplus (064290): a narrow, deep leader exposed to the quad expansion of foundry, packaging, and memory
Intekplus is the narrow, deep leader at the inspection chokepoint of the semiconductor quad capex cycle. But the turnaround expectation is already in the price, and the next move up must be proven by 2027 order disclosures.
2H 2026 Intel ultra-large substrate inspection order disclosure, OSAT/EMIB path volume, and Ibiden/Zhen Ding/Samsung Electro-Mechanics FC-BGA expansion orders.
Winners: Intekplus (large-area/high-density inspection edge), Gigavis (same FC-BGA cycle). Pressured: Japan's Takaoka (side-lighting limits), global giants KLA/Onto (wafer/metrology domain).
Intekplus makes optical inspection equipment that examines the surfaces of chips and substrates, finding microscopic defects with light that the human eye cannot catch. The business runs in three streams.
Semiconductor package inspection. Inspects all six faces of a finished chip. Customers have expanded to Intel, Samsung Electronics, SK Hynix, CXMT, TSMC, and Taiwanese OSATs.
substrate inspection. Measures the height and spacing of bumps on substrates in 3D. Customers include Samsung Electro-Mechanics, LG Innotek, Ibiden, Shinko, Toppan, and Zhen Ding.
Display and battery surface inspection. Contribution is limited.
Intekplus has a foot in both the back-end packaging and substrate markets through inspection. So the first thing to look at is the bigger picture pushing both markets up at once.
This company sits at the inspection chokepoint of both chips and substrates.
Sign in with Google to unlock the full body of every free report instantly.
Sign in with GoogleThis site runs on ads — the tier system rewards community contributions.
This report is provided for informational purposes only and does not constitute a recommendation to buy or sell any financial instrument. Investment decisions should be made based on your own judgment and responsibility. The analysis and opinions contained herein are based on information available at the time of writing and are subject to change.